blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2273974

EP2273974 - PROGUANIL TO TREAT SKIN/MUCOSAL DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.05.2014
Database last updated on 11.09.2024
Most recent event   Tooltip16.05.2014Application deemed to be withdrawnpublished on 18.06.2014  [2014/25]
Applicant(s)For all designated states
Tolmar, Inc.
701 Centre Avenue
Fort Collins, CO 80526 / US
[2011/03]
Inventor(s)01 / GODOWSKI, Kenneth
2213 Grosvenor Court
Fort Collins CO 80526 / US
 [2011/03]
Representative(s)Danner, Stefan, et al
LifeTech IP
Spies Danner & Partner
Patentanwälte PartG mbB
Elsenheimerstrasse 47a
80687 München / DE
[N/P]
Former [2014/11]Danner, Stefan, et al
LifeTech IP
Spies Danner & Partner Patentanwälte PartG mbB
Sankt-Martin-Strasse 53-55
81669 München / DE
Former [2013/12]Danner, Stefan, et al
DR. VOLKER VOSSIUS
Patent- und Rechtsanwaltskanzlei
Partnerschaft
Geibelstrasse 6
81679 München / DE
Former [2013/11]Danner, Stefan, et al
Dr. Volker Vossius
Patentanwälte - Rechtsanwälte
Partnerschaftsgesellschaft
Geibelstrasse 6
81679 München / DE
Former [2011/03]Dilg, Haeusler, Schindelmann Patentanwaltsgesellschaft mbH
Leonrodstrasse 58
DE-80636 München / DE
Application number, filing date09743087.008.05.2009
[2011/03]
WO2009US02879
Priority number, dateUS2008005181209.05.2008         Original published format: US 51812
[2011/03]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009137100
Date:12.11.2009
Language:EN
[2009/46]
Type: A2 Application without search report 
No.:EP2273974
Date:19.01.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 12.11.2009 takes the place of the publication of the European patent application.
[2011/03]
Search report(s)International search report - published on:EP22.07.2010
ClassificationIPC:A61K9/00, A61K31/155, A61P17/00
[2011/03]
CPC:
A61K9/0014 (EP,US); A61K31/155 (EP,US); A61K9/0034 (EP,US);
A61P17/00 (EP); A61P9/00 (EP); A61K9/122 (EP,US);
Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/03]
TitleGerman:PROGUANIL ZUR BEHANDLUNG VON HAUT-/SCHLEIMHAUTERKRANKUNGEN[2011/03]
English:PROGUANIL TO TREAT SKIN/MUCOSAL DISEASES[2011/03]
French:PROGUANIL POUR LE TRAITEMENT DES MALADIES DE PEAU/DES MUQUEUSES[2011/03]
Entry into regional phase22.11.2010National basic fee paid 
22.11.2010Designation fee(s) paid 
26.11.2010Examination fee paid 
Examination procedure07.09.2010Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.11.2010Amendment by applicant (claims and/or description)
26.11.2010Examination requested  [2011/03]
06.12.2011Despatch of a communication from the examining division (Time limit: M04)
10.04.2012Reply to a communication from the examining division
25.07.2013Despatch of a communication from the examining division (Time limit: M04)
05.12.2013Application deemed to be withdrawn, date of legal effect  [2014/25]
13.01.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/25]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.12.2011
Fees paidRenewal fee
11.05.2011Renewal fee patent year 03
29.03.2012Renewal fee patent year 04
10.05.2013Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]FR2320735  (DABIS GEORGES [FR]) [X] 1-24 * the whole document *;
 [A]WO2008005276  (DIRECTCONTACT LLC [US], et al) [A] 1-24 * the whole document *;
 [A]WO2006053160  (CELGENE CORP [US], et al) [A] 1-24 * the whole document *;
 [A]  - SEAL DAVID, "Treatment of Acanthamoeba keratitis", EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, FUTURE DRUGS, (20030801), vol. 1, no. 2, ISSN 1478-7210, pages 205 - 208, XP008093290 [A] 1-24 * the whole document *

DOI:   http://dx.doi.org/10.1586/14787210.1.2.205
 [A]  - HORACEK J, "Absorption spectrum of antimalarials related to their clinical efficiency in the treatment of discoid lupus erythematosus", CESKOSLOVENSKA DERMATOLOGIE, CESKA LEKARSKA SPOLECNOST J.E. PURKYNE, PRAGUE, CZ, (19590101), vol. 24, no. 1, ISSN 0009-0514, pages 39 - 44, XP008121915 [A] 1-24 * the whole document *
 [A]  - CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20010422), Database accession no. 51:57294, URL: stn, XP002581322 [A] 1-24 * the whole document *
 [A]  - V. VILLARI ET AL., "Antibacterial action in vitro of paludrine combined with aureomycin and with chloramphenicol", RIV. IST. SIEROTERAP. ITAL., (1957), vol. 32, pages 44 - 46 [A] 1-24
 [A]  - CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20010422), Database accession no. 45:41845, URL: stn, XP002581323 [A] 1-24 * the whole document *
    [ ] - M. SIRSI ET AL., "In vitro study of acridine biguanide derivatives upon some pathogenic microorganisms", CURRENT SCIENCE, (1950), vol. 19, pages 293 - 294
 [A]  - CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20010422), Database accession no. 52:106827, URL: STN, XP002581324 [A] 1-24 * the whole document *
    [ ] - T. CHRUSCIEL ET AL., "Pharmacological properties of the biologically active metabolite of paludrine and its bromo and iodo derivatives", DISSERTATIONES PHARMACEUTICAE, (1958), vol. 10, pages 81 - 91
ExaminationUS2006269485
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.